Skip Navigation
The Collection
Narrow By
1 - 20 of 2367
STUDY
Paid malpractice claims for adverse events in inpatient and outpatient settings.
Bishop TF, Ryan AK, Casalino LP. JAMA. 2011;305:2427-2431.
NEWSPAPER/MAGAZINE ARTICLE
Your attention please... designing effective warnings.
ISMP Medication Safety Alert! Acute Care Edition. August 24, 2006;11:1-3.
COMMENTARY
Look-alike and sound-alike medicines: risks and 'solutions.'
Emmerton LM, Rizk MFS. Int J Clin Pharm. 2012;34:4-8.
STUDY
Development and pilot testing of guidelines to monitor high-risk medications in the ambulatory setting.
Tjia J, Field TS, Garber LD, et al. Am J Manag Care. 2010;16:489-496.
NEWSPAPER/MAGAZINE ARTICLE
Neuromuscular blocking agents: reducing associated wrong-drug errors.
PA-PSRS Patient Saf Advis. December 2009;6:109-114.
NEWSPAPER/MAGAZINE ARTICLE
Results of ISMP survey on high-alert medications: differences between nursing, pharmacy, and risk/quality/safety perspectives.
ISMP Medication Safety Alert! Acute Care Edition. February 9, 2012;17:1-4.
STUDY
Time-dependent drug–drug interaction alerts in care provider order entry: software may inhibit medication error reductions.
van der Sijs H, Lammers L, van den Tweel A, et al. J Am Med Inform Assoc. 2009;16:864-868.
PRESS RELEASE/ANNOUNCEMENT
Medication errors resulting from confusion between risperidone (Risperdal) and ropinirole (Requip).
MedWatch Safety Alert, FDA Drug Safety Communication. Silver Spring, MD: US Food and Drug Administration; June 13, 2011.
COMMENTARY
In Conversation with...Allan Frankel, MD
AHRQ WebM&M [serial online]. July 2006.
STUDY
An in-depth analysis of medication errors in hospitalized patients with HIV.
Snyder AM, Klinker K, Orrick JJ, Janelle J, Winterstein AG. Ann Pharmacother. 2011;45:459-468.
COMMENTARY
ISMP medication error report analysis.
Cohen MR, Smetzer JL. Hosp Pharm. 2010:45;352-355. 
COMMENTARY
Interpreting the Patient Safety Literature
Shojania KG. AHRQ WebM&M [serial online]. June 2005.
PRESS RELEASE/ANNOUNCEMENT
Important Warnings and Instructions for Heparin Sodium Injection (Baxter).
FDA Public Health Advisory [US Food and Drug Administration Web site]. February 28, 2008.
STUDY
Improving ambulatory prescribing safety with a handheld decision support system: a randomized controlled trial.
Berner ES, Houston TK, Ray MN, et al. J Am Med Inform Assoc. 2006;13:171-179.
STUDY
Post-discharge medication reviews for patients with heart failure: a pilot study.
Ponniah A, Shakib S, Doecke CJ, Boyce M, Angley M. Pharm World Sci. 2008;30:810-815.
STUDYclassic
Measuring safety culture in the ambulatory setting: The Safety Attitudes Questionnaire—Ambulatory Version.
Modak I, Sexton JB, Lux TR, Helmreich RL, Thomas EJ. J Gen Intern Med. 2007;22:1-5.
STUDY
Drug formulations that require potentially inaccurate volumes to prepare doses for infants and children.
Uppal N, Yasseen B, Seto W, Parshuram CS. CMAJ. 2011;183:E246-E248.
BOOK/REPORT
With Safety in Mind: Mental Health Services and Patient Safety.
Scobie S, Minghella E, Dale C, Thomson R, Lelliott P, Hill K. London, UK: National Patient Safety Agency; July 2006.
1 2 3 4 5 6 7 8 9 10 11Next >